Recital 9, Commission Regulation (EU) No 712/2012 of 3 August 2012 amending Regulation (EC) No 1234…

In forcesince 3 Aug 2012

The European Medicines Agency has the expertise to assess the need for urgent safety restrictions regarding medicinal products authorised under the centralised procedure. Marketing authorisation holders of medicinal products authorised under Regulation (EC) No 726/2004 should therefore inform the Agency if they consider that urgent safety measures are necessary.